Long-term survival benefit of ruxolitinib in a patient with relapsed refractory chronic active Epstein-Barr virus

Ann Hematol. 2019 Aug;98(8):2003-2004. doi: 10.1007/s00277-019-03647-5. Epub 2019 Mar 4.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Child
  • Chronic Disease
  • DNA, Viral / blood
  • Drug Resistance, Viral
  • Epstein-Barr Virus Infections / drug therapy*
  • Etoposide / therapeutic use
  • Fever / etiology
  • Ganciclovir / therapeutic use
  • Herpesvirus 4, Human / isolation & purification
  • Humans
  • Male
  • Methylprednisolone / therapeutic use
  • Nitriles
  • Protein Kinase Inhibitors / therapeutic use*
  • Pyrazoles / therapeutic use*
  • Pyrimidines
  • Recurrence
  • Splenomegaly / etiology
  • Viral Load
  • Viremia / drug therapy*

Substances

  • DNA, Viral
  • Nitriles
  • Protein Kinase Inhibitors
  • Pyrazoles
  • Pyrimidines
  • Etoposide
  • ruxolitinib
  • Ganciclovir
  • Methylprednisolone